In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Optimizing RAAS inhibitor therapy in heart failure and resistant hypertension: challenges and solutions
Session

Event : ESC Congress 2016

Topic : Chronic Heart Failure - Other

  • Session type : EBAC Accredited Educational Programme
  • Date : 30 August 2016
  • Time : 12:45 - 13:45
  • Organised by Lorraine University / Course Director: Dr. Faiez Zannad / Supported by an unrestricted educational grant from AstraZeneca

5 presentations in this session

Introduction - Optimizing RAAS inhibitor therapy in heart failure and resistant hypertension: challenges and solutions.

Event : ESC Congress 2016

  • Session : Optimizing RAAS inhibitor therapy in heart failure and resistant hypertension: challenges and solutions
  • Speaker : F Zannad (Vandoeuvre,FR)
  • Organised by Lorraine University / Course Director: Dr. Faiez Zannad / Supported by an unrestricted educational grant from AstraZeneca

RAAS inhibition in heart failure: are we hitting the target?

Event : ESC Congress 2016

  • Session : Optimizing RAAS inhibitor therapy in heart failure and resistant hypertension: challenges and solutions
  • Speaker : S Anker (Berlin,DE)
  • Organised by Lorraine University / Course Director: Dr. Faiez Zannad / Supported by an unrestricted educational grant from AstraZeneca

Optimizing therapy for the management of resistant hypertension: time to focus on potassium?

Event : ESC Congress 2016

  • Session : Optimizing RAAS inhibitor therapy in heart failure and resistant hypertension: challenges and solutions
  • Speaker : LM Ruilope (Madrid,ES)
  • Organised by Lorraine University / Course Director: Dr. Faiez Zannad / Supported by an unrestricted educational grant from AstraZeneca

Hyperkalemia: novel treatment strategies to manage potassium levels.

Event : ESC Congress 2016

  • Session : Optimizing RAAS inhibitor therapy in heart failure and resistant hypertension: challenges and solutions
  • Speaker : M Kosiborod (Kansas,US)
  • Organised by Lorraine University / Course Director: Dr. Faiez Zannad / Supported by an unrestricted educational grant from AstraZeneca

Panel discussion - Optimizing RAAS inhibitor therapy in heart failure and resistant hypertension: challenges and solutions.

Event : ESC Congress 2016

  • Session : Optimizing RAAS inhibitor therapy in heart failure and resistant hypertension: challenges and solutions
  • Speaker : F Zannad (Vandoeuvre,FR), S Anker (Berlin,DE), LM Ruilope (Madrid,ES), M Kosiborod (Kansas,US)
  • Organised by Lorraine University / Course Director: Dr. Faiez Zannad / Supported by an unrestricted educational grant from AstraZeneca

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are